This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across innovations in precision medicine, targeted drug delivery, RNA editing, biomanufacturing, cell and gene therapies. The research also comprises advances in single cell analysis, hybrid microbots, AI-powered diagnostic, bioprinting and non-communicable disease management technologies.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Precision Medicine, Immunomodulation, Inflammatory Diseases, Immunotherapy, Antibody-drug conjugate, targeted drug delivery, cell and gene therapy, CGT manufacturing, RNA editing, AAV, gene therapy, central nervous system (CNS) disorders, circular RNA vaccine, single cell analysis, AI-powered algorithm, coronary artery diseases, plaque morphology, hybrid microbots, high throughput bioprinting, brain scanners, RNAi therapies, GIP Antagonist, Leukemia, hemophilia, T-cell engagers,